Financials
- Market Capitalization 2.49 B
- Employee 361
- Founded 2016
- CEO N/A
- Website www.veratx.com
- Headquarter Delaware, United States
- FIGI BBG00Q72WYG3
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-10.87
ratio cours/chiffre d'affaires
7 992.14
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1849 | NKTR Nektar Therapeutics - Common Stock | 74.55 USD | +1.06% | -0.73% | +4.72% | +1.75% | 2.55 B USD | ||
| 1854 | BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 9.87 USD | +0.41% | +2.07% | +2.17% | +16.67% | 2.52 B USD | ||
| 1871 | KOD Kodiak Sciences Inc - Common Stock | 39.12 USD | -0.53% | -3.14% | -3.43% | +335.15% | 2.46 B USD | ||
| 1872 | NUVB Nuvation Bio Inc. Class A Common Stock | 7.00 USD | +0.86% | +0.29% | +5.42% | +136.49% | 2.46 B USD |